TABLE 7.

Graft loss development according to occurrence and characteristics of antibodies.

Evaluated patients (n = 146)	Number of patients (total)	Number of patients with graft loss	AIC*	P-value
Model with dnHLA-DSAs	50	14	111.17	<0.001
Model with Q4-GSTTAbs	16	8	108.06	<0.001
Model with dnHLA-DSA+ Q4-GSTTAbs+	11	7	99.54	<0.001

Cox models performance using AIC with each candidate predictor, separately, and combined in a bivariable analysis. *The Akaike Information criterion (AIC) was computed in a combined model. The p-value of Cox proportional-hazard model is reported. Q4-GSTTAbs, GSTTAbs with MFI levels in the 4th quartile.